Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: Taiwan Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20064
20072
20081
20094
20103
20116
20122
20133
20142
20151
20161
20185
20194
20203
20214
20224
20233
20243
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting10
Terminated9
Unknown status6
Active, not recruiting5
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital8
National Taiwan University Hospital7
Bayer4
Novartis Pharmaceuticals3
Bristol-Myers Squibb2
Coherus Oncology, Inc.2
Hoffmann-La Roche2
Kaohsiung Medical University Chung-Ho Memorial Hospital2
National Health Research Institutes, Taiwan2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular64
Liver Neoplasms9
Neoplasms7
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Ovarian Neoplasms3
Cholangiocarcinoma2
Hepatitis B, Chronic2
Neoplasm Metastasis2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.